Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054496
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2003-02-05
Brief Title:
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Sponsor:
The Cleveland Clinic
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000270723
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Cleveland Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None